MRNA - Moderna, Inc.


57.8
7.970   13.789%

Share volume: 22,334,586
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%

$49.83
7.97
0.16%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-02-2024 08-01-2024 11-07-2024 02-21-2025 05-01-2025 08-01-2025 11-06-2025 02-20-2026
Total revenue 167.000 M 241.000 M 1.862 B 966.000 M 108.000 M 142.000 M 1.016 B 678.000 M
Cost of revenue 96.000 M 115.000 M 514.000 M 739.000 M 90.000 M 119.000 M 207.000 M 452.000 M
Gross profit 71.000 M 126.000 M 1.348 B 227.000 M 18.000 M 23.000 M 809.000 M 226.000 M
    77.46% 969.84% -83.16% -92.07% 27.78% 3,417.39% -72.06%  
Operating expenses 1.337 B 1.489 B 1.418 B 1.473 B 1.068 B 930.000 M 1.069 B 1.083 B
Selling general and admin 274.000 M 268.000 M 281.000 M 351.000 M 212.000 M 230.000 M 268.000 M 308.000 M
Research and development 1.063 B 1.221 B 1.137 B 1.122 B 856.000 M 700.000 M 801.000 M 775.000 M
Total expenses 1.337 B 1.489 B 1.418 B 1.473 B 1.068 B 930.000 M 1.069 B 1.083 B
    11.37% -4.77% 3.88% -27.49% -12.92% 14.95% 1.31%  
Operating income -1.266 B -1.363 B -70.000 M -1.246 B -1.050 B -907.000 M -260.000 M -857.000 M
Ebit -1.285 B -1.390 B -82.000 M -1.275 B -1.054 B -899.000 M -260.000 M -869.000 M
Pretax income -1.165 B -1.279 B 21.000 M -1.184 B -964.000 M -818.000 M -187.000 M -799.000 M
    9.79% -101.64% -5,738.10% -18.58% -15.15% -77.14% 327.27%  
Income tax 10.000 M 0.000 8.000 M -64.000 M 7.000 M 7.000 M 13.000 M 27.000 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -1.175 B -1.279 B 13.000 M -1.120 B -971.000 M -825.000 M -200.000 M -826.000 M
    -8.85% 101.02% -8,715.38% 13.30% 15.04% 75.76% -313.00%